Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Technology (PCR, ISH, INAAT), By End-use, By Application, By Region, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 48 Business Hours
Infectious Disease Molecular Diagnostics Market Growth & Trends
The global infectious disease molecular diagnostics market size is expected to reach USD 40.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 3.0% from 2020 to 2028. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings.
Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies.
Technologies such as INAAT, mass spectroscopy, and ISH are advanced and have a low false-positive rate as compared to other traditional diagnostic tests. Advantages such as the cost-effectiveness and user-friendliness of this technology and the accuracy offered are estimated to increase the adoption of this technology.
The use of molecular diagnostics in research institutes is increasing. The use of techniques such as PCR, western blotting, and southern blotting is becoming common. Moreover, the spread of SARS-CoV-2 infection globally has led to an increase in research funding by governments as well as diagnostic companies to search for innovative molecular diagnostics.
Molecular diagnostics deliver effective and accurate results. Moreover, these tests enable the early detection of diseases, maintaining a low threat of substitutes. However, the high prices of these tests are expected to encourage patients to shift to external substitutes. Moreover, for the detection of newer infections such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry.
Infectious Disease Molecular Diagnostics Market Report Highlights
Infectious Disease Molecular Diagnostics Market Growth & Trends
The global infectious disease molecular diagnostics market size is expected to reach USD 40.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 3.0% from 2020 to 2028. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings.
Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies.
Technologies such as INAAT, mass spectroscopy, and ISH are advanced and have a low false-positive rate as compared to other traditional diagnostic tests. Advantages such as the cost-effectiveness and user-friendliness of this technology and the accuracy offered are estimated to increase the adoption of this technology.
The use of molecular diagnostics in research institutes is increasing. The use of techniques such as PCR, western blotting, and southern blotting is becoming common. Moreover, the spread of SARS-CoV-2 infection globally has led to an increase in research funding by governments as well as diagnostic companies to search for innovative molecular diagnostics.
Molecular diagnostics deliver effective and accurate results. Moreover, these tests enable the early detection of diseases, maintaining a low threat of substitutes. However, the high prices of these tests are expected to encourage patients to shift to external substitutes. Moreover, for the detection of newer infections such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry.
Infectious Disease Molecular Diagnostics Market Report Highlights
- The reagent segment is expected to exhibit the fastest growth rate attributable to increased adoption
- The growing geriatric population in Asian countries, such as Japan and China, with high untapped opportunities is expected to drive the market for infectious disease molecular diagnostics in the region during the forecast period
- The In Situ Hybridization (ISH) segment is anticipated to witness the fastest growth rate owing to high sensitivity and lower complexity
- The high growth rate of the market for infectious disease molecular diagnostics in the Asia Pacific can be attributed to increased access to healthcare in the developing nations
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Infectious Disease Molecular Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 User Perspective Analysis
3.3 Penetration & Growth Prospect Mapping
3.4 Regulatory and Reimbursement Framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Increase in geriatric population
3.5.1.2 Introduction of technologically advanced products
3.5.1.3 Increase in demand for point-of-care Daignostics
3.5.1.4 Growing prevalence of target diseases
3.5.1.5 Increasing external funding for R&D
3.5.1.6 Outbreak of COVID-19
3.5.2 Market restraint analysis
3.5.2.1 Presence of ambiguous regulatory framework
3.5.2.2 High prices of Infectious Disease Molecular Diagnostics tests
3.6 Infectious Disease Molecular Diagnostics Market Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.3 Major deals & strategic alliances analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Market entry strategies
CHAPTER 4 PRODUCTS BUSINESS ANALYSIS
4.1 Infectious Disease Molecular Diagnostics Market: Products Movement Analysis
4.1.1 Instruments
4.1.1.1 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
4.1.2 Reagents
4.1.2.1 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
4.1.3 Services
4.1.3.1 Services market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 5 TECHNOLOGY BUSINESS ANALYSIS
5.1 Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis
5.1.1 Polymerase Chain Reaction
5.1.1.1 Polymerase chain reaction market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.2 PCR Market by type
5.1.1.2.1 Multiplex PCR
5.1.1.2.1.1 Multiplex PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.2.2 Other PCR
5.1.1.2.2.1 Other PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3 PCR market, by Product
5.1.1.3.1 Instruments
5.1.1.3.1.1 Instruments PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3.2 Reagents
5.1.1.3.2.1 Reagents PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3.3 Services
5.1.1.3.3.1 Services PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2 In Situ Hybridization (ISH)
5.1.2.1 In Situ Hybridization market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.2 Instruments
5.1.2.2.1 Instruments ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.3 Reagents
5.1.2.3.1 Reagents ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.4 Others
5.1.2.4.1 Others ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.1.3.1 INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.2 Instruments
5.1.3.2.1 Instruments INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.3 Reagents
5.1.3.3.1 Reagents INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.4 Services
5.1.3.4.1 Services INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4 Chips and Microarrays
5.1.4.1 Chips and Microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.2 Instruments
5.1.4.2.1 Instruments chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.3 Reagents
5.1.4.3.1 Reagents chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.4 Services
5.1.4.4.1 Services chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5 Mass Spectrometry
5.1.5.1 Mass Spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.2 Instruments
5.1.5.2.1 Instruments mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.3 Reagents
5.1.5.3.1 Reagents mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.4 Services
5.1.5.4.1 Services mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6 Sequencing
5.1.6.1 Sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.2 Instruments
5.1.6.2.1 Instruments sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.3 Reagents
5.1.6.3.1 Reagents sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.4 Services
5.1.6.4.1 Services sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7 Transcription Mediated Amplification (TMA)
5.1.7.1 TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.2 Instruments
5.1.7.2.1 Instruments TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.3 Reagents
5.1.7.3.1 Reagents TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.4 Services
5.1.7.4.1 Services TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8 Others
5.1.8.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.2 Instruments
5.1.8.2.1 Instruments others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.3 Reagents
5.1.8.3.1 Reagents others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.4 Services
5.1.8.4.1 Services market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 6 END-USE BUSINESS ANALYSIS
6.1 Molecular Diagnostics Market: End-use Movement Analysis
6.1.1 Hospitals
6.1.1.1 Hospitals market estimates and forecast, 2017 - 2028 (USD Million)
6.1.2 Clinics
6.1.2.1 Clinics market estimates and forecast, 2017 - 2028 (USD Million)
6.1.3 Diagnostic laboratories
6.1.3.1 Diagnostic laboratories market estimates and forecast, 2017 - 2028 (USD Million)
6.1.4 Research Institutes
6.1.4.1 Research Institutes market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 7 APPLICATION BUSINESS ANALYSIS
7.1 Molecular Diagnostics Market: Application Movement Analysis
7.1.1 Respiratory Diseases
7.1.1.1 Respiratory diseases market estimates and forecast, 2017 - 2028 (USD Million)
7.1.2 Tuberculosis
7.1.2.1 Tuberculosis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.3 Meningitis
7.1.3.1 Meningitis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.4 Gastrointestinal Tract Infections
7.1.4.1 Gastrointestinal tract infections market estimates and forecast, 2017 - 2028 (USD Million)
7.1.5 HPV
7.1.5.1 HPV market estimates and forecast, 2017 - 2028 (USD Million)
7.1.6 Sexually Transmitted Infections
7.1.6.1 Sexually transmitted infections market estimates and forecast, 2017 - 2028 (USD Million)
7.1.7 Sepsis
7.1.7.1 Sepsis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.8 Drug Resistance Disease
7.1.8.1 Drug resistance disease market estimates and forecast, 2017 - 2028 (USD Million)
7.1.9 Other Infectious Diseases
7.1.9.1 Other infectious diseases market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 8 RESPIRATORY DISEASES MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
8.1 Product Movement Analysis & Market Share, 2020 & 2028
8.1.1 Instruments
8.1.2 Reagents
8.1.3 Services
8.2 End-use Movement Analysis & Market Share, 2020 & 2028
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Diagnostic Laboratories
8.2.4 Research Institutes
8.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
8.3.1 Polymerase Chain Reaction (PCR)
8.3.2 In Situ Hybridization
8.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.4 Chips and Microarrays
8.3.5 Mass Spectrometry
8.3.6 Sequencing
8.3.7 Transcription Mediated Amplification
8.3.8 Others
CHAPTER 9 TUBERCULOSIS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
9.1 Product Movement Analysis & Market Share, 2020 & 2028
9.1.1 Instruments
9.1.2 Reagents
9.1.3 Services
9.2 End-use Movement Analysis & Market Share, 2020 & 2028
9.2.1 Hospitals
9.2.2 Clinics
9.2.3 Diagnostic Laboratories
9.2.4 Research Institutes
9.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
9.3.1 Polymerase Chain Reaction (PCR)
9.3.2 In Situ Hybridization
9.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.4 Chips and Microarrays
9.3.5 Mass Spectrometry
9.3.6 Sequencing
9.3.7 Transcription Mediated Amplification
9.3.8 Others
CHAPTER 10 MENINGITIS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
10.1 Product Movement Analysis & Market Share, 2020 & 2028
10.1.1 Instruments
10.1.2 Reagents
10.1.3 Services
10.2 End-use Movement Analysis & Market Share, 2020 & 2028
10.2.1 Hospitals
10.2.2 Clinics
10.2.3 Diagnostic Laboratories
10.2.4 Research Institutes
10.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
10.3.1 Polymerase Chain Reaction (PCR)
10.3.2 In Situ Hybridization
10.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
10.3.4 Chips and Microarrays
10.3.5 Mass Spectrometry
10.3.6 Sequencing
10.3.7 Transcription Mediated Amplification
10.3.8 Others
CHAPTER 11 GASTROINTESTINAL TRACT INFECTIONS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017- 2028, (USD MILLION)
11.1 Product Movement Analysis & Market Share, 2020 & 2028
11.1.1 Instruments
11.1.2 Reagents
11.1.3 Services
11.2 End-use Movement Analysis & Market Share, 2020 & 2028
11.2.1 Hospitals
11.2.2 Clinics
11.2.3 Diagnostic Laboratories
11.2.4 Research Institutes
11.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
11.3.1 Polymerase Chain Reaction (PCR)
11.3.2 In Situ Hybridization
11.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.3.4 Chips and Microarrays
11.3.5 Mass Spectrometry
11.3.6 Sequencing
11.3.7 Transcription Mediated Amplification
11.3.8 Others
CHAPTER 12 HPV-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
12.1 Product Movement Analysis & Market Share, 2020 & 2028
12.1.1 Instruments
12.1.2 Reagents
12.1.3 Services
12.2 End-use Movement Analysis & Market Share, 2020 & 2028
12.2.1 Hospitals
12.2.2 Clinics
12.2.3 Diagnostic Laboratories
12.2.4 Research Institutes
12.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
12.3.1 Polymerase Chain Reaction (PCR)
12.3.2 In Situ Hybridization
12.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
12.3.4 Chips and Microarrays
12.3.5 Mass Spectrometry
12.3.6 Sequencing
12.3.7 Transcription Mediated Amplification
12.3.8 Others
CHAPTER 13 SEXUALLY TRANSMITTED INFECTIONS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017- 2028, (USD MILLION)
13.1 Product Movement Analysis & Market Share, 2020 & 2028
13.1.1 Instruments
13.1.2 Reagents
13.1.3 Services
13.2 End-use Movement Analysis & Market Share, 2020 & 2028
13.2.1 Hospitals
13.2.2 Clinics
13.2.3 Diagnostic Laboratories
13.2.4 Research Institutes
13.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
13.3.1 Polymerase Chain Reaction (PCR)
13.3.2 In Situ Hybridization
13.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
13.3.4 Chips and Microarrays
13.3.5 Mass Spectrometry
13.3.6 Sequencing
13.3.7 Transcription Mediated Amplification
13.3.8 Others
CHAPTER 14 SEPSIS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
14.1 Product Movement Analysis & Market Share, 2020 & 2028
14.1.1 Instruments
14.1.2 Reagents
14.1.3 Services
14.2 End-use Movement Analysis & Market Share, 2020 & 2028
14.2.1 Hospitals
14.2.2 Clinics
14.2.3 Diagnostic Laboratories
14.2.4 Research Institutes
14.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
14.3.1 Polymerase Chain Reaction (PCR)
14.3.2 In Situ Hybridization
14.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
14.3.4 Chips and Microarrays
14.3.5 Mass Spectrometry
14.3.6 Sequencing
14.3.7 Transcription Mediated Amplification
14.3.8 Others
CHAPTER 15 DRUG RESISTANCE INFECTIONS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
15.1 Product Movement Analysis & Market Share, 2020 & 2028
15.1.1 Instruments
15.1.2 Reagents
15.1.3 Services
15.2 End-use Movement Analysis & Market Share, 2020 & 2028
15.2.1 Hospitals
15.2.2 Clinics
15.2.3 Diagnostic Laboratories
15.2.4 Research Institutes
15.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
15.3.1 Polymerase Chain Reaction (PCR)
15.3.2 In Situ Hybridization
15.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
15.3.4 Chips and Microarrays
15.3.5 Mass Spectrometry
15.3.6 Sequencing
15.3.7 Transcription Mediated Amplification
15.3.8 Others
CHAPTER 16 INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET: REGIONAL MARKET ANALYSIS, 2017 - 2028 (USD MILLION)
16.1 Definition & Scope
16.2 Regional Market Share Analysis, 2020 & 2028
16.3 Regional Market Dashboard
16.4 Regional Market Snapshot
16.5 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
16.6 North America
16.6.1 North America Market estimates and forecast, 2017 - 2028 (USD Million)
16.6.2 U.S.
16.6.2.1 U.S. Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.6.3 Canada
16.6.3.1 Canada Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7 Europe
16.7.1 Europe Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.2 U.K.
16.7.2.1 U.K. Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.3 Germany
16.7.3.1 Germany Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.4 Spain
16.7.4.1 Spain Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.5 France
16.7.5.1 France Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.6 Italy
16.7.6.1 Italy Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8 Asia Pacific
16.8.1 Asia Pacific Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.2 Japan
16.8.2.1 Japan Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.3 China
16.8.3.1 China Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.4 India
16.8.4.1 India Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.5 South Korea
16.8.5.1 South Korea Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.6 Australia
16.8.6.1 Australia Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9 Latin America
16.9.1 Latin America Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.2 Brazil
16.9.2.1 Brazil Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.3 Mexico
16.9.3.1 Mexico Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.4 Argentina
16.9.4.1 Argentina Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10 MEA
16.10.1 MEA Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.2 South Africa
16.10.2.1 South Africa Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.3 Saudi Arabia
16.10.3.1 Saudi Arabia Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.4 UAE
16.10.4.1 UAE Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
CHAPTER 17 COMPETITIVE LANDSCAPE
17.1 Recent Developments and Impact Analysis, by Key Market Participants
17.1.1 Ansoff matrix
17.2 Company Categorization
17.2.1 Innovators
17.2.2 Market Leaders
17.3 Vendor Landscape
17.3.1 List of key distributors and channel partners
17.3.2 Key customers
17.4 Public Companies
17.4.1 Company market position analysis
17.4.2 Competitive Dashboard Analysis
17.4.2.1 Market Differentiators
17.5 Private Companies
17.5.1 List of key emerging companies
17.6 Company Profiles
17.6.1 Abbott
17.6.1.1 Company overview
17.6.1.2 Alere, Inc.
17.6.1.3 Financial performance
17.6.1.4 Product benchmarking
17.6.1.5 Strategic initiatives
17.6.2 Becton, Dickinson and Company
17.6.2.1 Company overview
17.6.2.2 Financial performance
17.6.2.3 Product benchmarking
17.6.2.4 Strategic initiatives
17.6.3 bioM?rieux SA
17.6.3.1 Company overview
17.6.3.2 Financial performance
17.6.3.3 Product benchmarking
17.6.3.4 Strategic initiatives
17.6.4 Bio-Rad Laboratories, Inc.
17.6.4.1 Company overview
17.6.4.2 Financial performance
17.6.4.3 Product benchmarking
17.6.4.4 Strategic initiatives
17.6.5 Agilent Technologies, Inc.
17.6.5.1 Company overview
17.6.5.2 Financial performance
17.6.5.3 Product benchmarking
17.6.5.4 Strategic initiatives
17.6.6 Danaher Corporation
17.6.6.1 Company overview
17.6.6.2 Cepheid
17.6.6.3 Beckman Coulter
17.6.6.4 Leica Biosystems
17.6.6.5 Financial performance
17.6.6.6 Product benchmarking
17.6.6.7 Strategic initiatives
17.6.6.8 Strategic initiatives of Cepheid
17.6.7 Hologic, Inc. (Gen Probe)
17.6.7.1 Company overview
17.6.7.2 Financial performance
17.6.7.3 Product benchmarking
17.6.7.4 Strategic initiatives
17.6.8 Illumina, Inc.
17.6.8.1 Company overview
17.6.8.2 Financial performance
17.6.8.3 Product benchmarking
17.6.8.4 Strategic initiatives
17.6.9 GRIFOLs S.A.
17.6.9.1 Company overview
17.6.9.2 Financial performance
17.6.9.3 Product benchmarking
17.6.9.4 Strategic initiatives
17.6.10 Qiagen
17.6.10.1 Company overview
17.6.10.2 Financial performance
17.6.10.3 Product benchmarking
17.6.10.4 Strategic initiatives
17.6.11 F. Hoffmann-La Roche Ltd
17.6.11.1 Company overview
17.6.11.2 Financial performance
17.6.11.3 Product benchmarking
17.6.11.4 Strategic initiatives
17.6.12 Siemens Healthineers
17.6.12.1 Company overview
17.6.12.2 Financial performance
17.6.12.3 Product benchmarking
17.6.12.4 Strategic initiatives
17.6.13 Sysmex Corporation
17.6.13.1 Company overview
17.6.13.2 Financial performance
17.6.13.3 Product benchmarking
17.6.13.4 Strategic initiatives
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Infectious Disease Molecular Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 User Perspective Analysis
3.3 Penetration & Growth Prospect Mapping
3.4 Regulatory and Reimbursement Framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Increase in geriatric population
3.5.1.2 Introduction of technologically advanced products
3.5.1.3 Increase in demand for point-of-care Daignostics
3.5.1.4 Growing prevalence of target diseases
3.5.1.5 Increasing external funding for R&D
3.5.1.6 Outbreak of COVID-19
3.5.2 Market restraint analysis
3.5.2.1 Presence of ambiguous regulatory framework
3.5.2.2 High prices of Infectious Disease Molecular Diagnostics tests
3.6 Infectious Disease Molecular Diagnostics Market Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.3 Major deals & strategic alliances analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Market entry strategies
CHAPTER 4 PRODUCTS BUSINESS ANALYSIS
4.1 Infectious Disease Molecular Diagnostics Market: Products Movement Analysis
4.1.1 Instruments
4.1.1.1 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
4.1.2 Reagents
4.1.2.1 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
4.1.3 Services
4.1.3.1 Services market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 5 TECHNOLOGY BUSINESS ANALYSIS
5.1 Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis
5.1.1 Polymerase Chain Reaction
5.1.1.1 Polymerase chain reaction market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.2 PCR Market by type
5.1.1.2.1 Multiplex PCR
5.1.1.2.1.1 Multiplex PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.2.2 Other PCR
5.1.1.2.2.1 Other PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3 PCR market, by Product
5.1.1.3.1 Instruments
5.1.1.3.1.1 Instruments PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3.2 Reagents
5.1.1.3.2.1 Reagents PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.1.3.3 Services
5.1.1.3.3.1 Services PCR market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2 In Situ Hybridization (ISH)
5.1.2.1 In Situ Hybridization market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.2 Instruments
5.1.2.2.1 Instruments ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.3 Reagents
5.1.2.3.1 Reagents ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2.4 Others
5.1.2.4.1 Others ISH market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.1.3.1 INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.2 Instruments
5.1.3.2.1 Instruments INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.3 Reagents
5.1.3.3.1 Reagents INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3.4 Services
5.1.3.4.1 Services INAAT market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4 Chips and Microarrays
5.1.4.1 Chips and Microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.2 Instruments
5.1.4.2.1 Instruments chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.3 Reagents
5.1.4.3.1 Reagents chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.4.4 Services
5.1.4.4.1 Services chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5 Mass Spectrometry
5.1.5.1 Mass Spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.2 Instruments
5.1.5.2.1 Instruments mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.3 Reagents
5.1.5.3.1 Reagents mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.5.4 Services
5.1.5.4.1 Services mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6 Sequencing
5.1.6.1 Sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.2 Instruments
5.1.6.2.1 Instruments sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.3 Reagents
5.1.6.3.1 Reagents sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.6.4 Services
5.1.6.4.1 Services sequencing market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7 Transcription Mediated Amplification (TMA)
5.1.7.1 TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.2 Instruments
5.1.7.2.1 Instruments TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.3 Reagents
5.1.7.3.1 Reagents TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.7.4 Services
5.1.7.4.1 Services TMA market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8 Others
5.1.8.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.2 Instruments
5.1.8.2.1 Instruments others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.3 Reagents
5.1.8.3.1 Reagents others market estimates and forecast, 2017 - 2028 (USD Million)
5.1.8.4 Services
5.1.8.4.1 Services market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 6 END-USE BUSINESS ANALYSIS
6.1 Molecular Diagnostics Market: End-use Movement Analysis
6.1.1 Hospitals
6.1.1.1 Hospitals market estimates and forecast, 2017 - 2028 (USD Million)
6.1.2 Clinics
6.1.2.1 Clinics market estimates and forecast, 2017 - 2028 (USD Million)
6.1.3 Diagnostic laboratories
6.1.3.1 Diagnostic laboratories market estimates and forecast, 2017 - 2028 (USD Million)
6.1.4 Research Institutes
6.1.4.1 Research Institutes market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 7 APPLICATION BUSINESS ANALYSIS
7.1 Molecular Diagnostics Market: Application Movement Analysis
7.1.1 Respiratory Diseases
7.1.1.1 Respiratory diseases market estimates and forecast, 2017 - 2028 (USD Million)
7.1.2 Tuberculosis
7.1.2.1 Tuberculosis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.3 Meningitis
7.1.3.1 Meningitis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.4 Gastrointestinal Tract Infections
7.1.4.1 Gastrointestinal tract infections market estimates and forecast, 2017 - 2028 (USD Million)
7.1.5 HPV
7.1.5.1 HPV market estimates and forecast, 2017 - 2028 (USD Million)
7.1.6 Sexually Transmitted Infections
7.1.6.1 Sexually transmitted infections market estimates and forecast, 2017 - 2028 (USD Million)
7.1.7 Sepsis
7.1.7.1 Sepsis market estimates and forecast, 2017 - 2028 (USD Million)
7.1.8 Drug Resistance Disease
7.1.8.1 Drug resistance disease market estimates and forecast, 2017 - 2028 (USD Million)
7.1.9 Other Infectious Diseases
7.1.9.1 Other infectious diseases market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 8 RESPIRATORY DISEASES MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
8.1 Product Movement Analysis & Market Share, 2020 & 2028
8.1.1 Instruments
8.1.2 Reagents
8.1.3 Services
8.2 End-use Movement Analysis & Market Share, 2020 & 2028
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Diagnostic Laboratories
8.2.4 Research Institutes
8.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
8.3.1 Polymerase Chain Reaction (PCR)
8.3.2 In Situ Hybridization
8.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.4 Chips and Microarrays
8.3.5 Mass Spectrometry
8.3.6 Sequencing
8.3.7 Transcription Mediated Amplification
8.3.8 Others
CHAPTER 9 TUBERCULOSIS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
9.1 Product Movement Analysis & Market Share, 2020 & 2028
9.1.1 Instruments
9.1.2 Reagents
9.1.3 Services
9.2 End-use Movement Analysis & Market Share, 2020 & 2028
9.2.1 Hospitals
9.2.2 Clinics
9.2.3 Diagnostic Laboratories
9.2.4 Research Institutes
9.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
9.3.1 Polymerase Chain Reaction (PCR)
9.3.2 In Situ Hybridization
9.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.4 Chips and Microarrays
9.3.5 Mass Spectrometry
9.3.6 Sequencing
9.3.7 Transcription Mediated Amplification
9.3.8 Others
CHAPTER 10 MENINGITIS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
10.1 Product Movement Analysis & Market Share, 2020 & 2028
10.1.1 Instruments
10.1.2 Reagents
10.1.3 Services
10.2 End-use Movement Analysis & Market Share, 2020 & 2028
10.2.1 Hospitals
10.2.2 Clinics
10.2.3 Diagnostic Laboratories
10.2.4 Research Institutes
10.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
10.3.1 Polymerase Chain Reaction (PCR)
10.3.2 In Situ Hybridization
10.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
10.3.4 Chips and Microarrays
10.3.5 Mass Spectrometry
10.3.6 Sequencing
10.3.7 Transcription Mediated Amplification
10.3.8 Others
CHAPTER 11 GASTROINTESTINAL TRACT INFECTIONS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017- 2028, (USD MILLION)
11.1 Product Movement Analysis & Market Share, 2020 & 2028
11.1.1 Instruments
11.1.2 Reagents
11.1.3 Services
11.2 End-use Movement Analysis & Market Share, 2020 & 2028
11.2.1 Hospitals
11.2.2 Clinics
11.2.3 Diagnostic Laboratories
11.2.4 Research Institutes
11.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
11.3.1 Polymerase Chain Reaction (PCR)
11.3.2 In Situ Hybridization
11.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.3.4 Chips and Microarrays
11.3.5 Mass Spectrometry
11.3.6 Sequencing
11.3.7 Transcription Mediated Amplification
11.3.8 Others
CHAPTER 12 HPV-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
12.1 Product Movement Analysis & Market Share, 2020 & 2028
12.1.1 Instruments
12.1.2 Reagents
12.1.3 Services
12.2 End-use Movement Analysis & Market Share, 2020 & 2028
12.2.1 Hospitals
12.2.2 Clinics
12.2.3 Diagnostic Laboratories
12.2.4 Research Institutes
12.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
12.3.1 Polymerase Chain Reaction (PCR)
12.3.2 In Situ Hybridization
12.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
12.3.4 Chips and Microarrays
12.3.5 Mass Spectrometry
12.3.6 Sequencing
12.3.7 Transcription Mediated Amplification
12.3.8 Others
CHAPTER 13 SEXUALLY TRANSMITTED INFECTIONS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017- 2028, (USD MILLION)
13.1 Product Movement Analysis & Market Share, 2020 & 2028
13.1.1 Instruments
13.1.2 Reagents
13.1.3 Services
13.2 End-use Movement Analysis & Market Share, 2020 & 2028
13.2.1 Hospitals
13.2.2 Clinics
13.2.3 Diagnostic Laboratories
13.2.4 Research Institutes
13.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
13.3.1 Polymerase Chain Reaction (PCR)
13.3.2 In Situ Hybridization
13.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
13.3.4 Chips and Microarrays
13.3.5 Mass Spectrometry
13.3.6 Sequencing
13.3.7 Transcription Mediated Amplification
13.3.8 Others
CHAPTER 14 SEPSIS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
14.1 Product Movement Analysis & Market Share, 2020 & 2028
14.1.1 Instruments
14.1.2 Reagents
14.1.3 Services
14.2 End-use Movement Analysis & Market Share, 2020 & 2028
14.2.1 Hospitals
14.2.2 Clinics
14.2.3 Diagnostic Laboratories
14.2.4 Research Institutes
14.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
14.3.1 Polymerase Chain Reaction (PCR)
14.3.2 In Situ Hybridization
14.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
14.3.4 Chips and Microarrays
14.3.5 Mass Spectrometry
14.3.6 Sequencing
14.3.7 Transcription Mediated Amplification
14.3.8 Others
CHAPTER 15 DRUG RESISTANCE INFECTIONS-MOLECULAR DIAGNOSTICS MARKET ANALYSIS, 2017 - 2028, (USD MILLION)
15.1 Product Movement Analysis & Market Share, 2020 & 2028
15.1.1 Instruments
15.1.2 Reagents
15.1.3 Services
15.2 End-use Movement Analysis & Market Share, 2020 & 2028
15.2.1 Hospitals
15.2.2 Clinics
15.2.3 Diagnostic Laboratories
15.2.4 Research Institutes
15.3 Technology Movement Analysis & Market Share, 2020 & 2028 (Number of Tests Performed)
15.3.1 Polymerase Chain Reaction (PCR)
15.3.2 In Situ Hybridization
15.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
15.3.4 Chips and Microarrays
15.3.5 Mass Spectrometry
15.3.6 Sequencing
15.3.7 Transcription Mediated Amplification
15.3.8 Others
CHAPTER 16 INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET: REGIONAL MARKET ANALYSIS, 2017 - 2028 (USD MILLION)
16.1 Definition & Scope
16.2 Regional Market Share Analysis, 2020 & 2028
16.3 Regional Market Dashboard
16.4 Regional Market Snapshot
16.5 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
16.6 North America
16.6.1 North America Market estimates and forecast, 2017 - 2028 (USD Million)
16.6.2 U.S.
16.6.2.1 U.S. Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.6.3 Canada
16.6.3.1 Canada Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7 Europe
16.7.1 Europe Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.2 U.K.
16.7.2.1 U.K. Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.3 Germany
16.7.3.1 Germany Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.4 Spain
16.7.4.1 Spain Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.5 France
16.7.5.1 France Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.7.6 Italy
16.7.6.1 Italy Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8 Asia Pacific
16.8.1 Asia Pacific Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.2 Japan
16.8.2.1 Japan Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.3 China
16.8.3.1 China Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.4 India
16.8.4.1 India Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.5 South Korea
16.8.5.1 South Korea Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.8.6 Australia
16.8.6.1 Australia Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9 Latin America
16.9.1 Latin America Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.2 Brazil
16.9.2.1 Brazil Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.3 Mexico
16.9.3.1 Mexico Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.9.4 Argentina
16.9.4.1 Argentina Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10 MEA
16.10.1 MEA Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.2 South Africa
16.10.2.1 South Africa Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.3 Saudi Arabia
16.10.3.1 Saudi Arabia Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
16.10.4 UAE
16.10.4.1 UAE Infectious Disease Molecular Diagnostics Market, 2017 - 2028 (USD Million)
CHAPTER 17 COMPETITIVE LANDSCAPE
17.1 Recent Developments and Impact Analysis, by Key Market Participants
17.1.1 Ansoff matrix
17.2 Company Categorization
17.2.1 Innovators
17.2.2 Market Leaders
17.3 Vendor Landscape
17.3.1 List of key distributors and channel partners
17.3.2 Key customers
17.4 Public Companies
17.4.1 Company market position analysis
17.4.2 Competitive Dashboard Analysis
17.4.2.1 Market Differentiators
17.5 Private Companies
17.5.1 List of key emerging companies
17.6 Company Profiles
17.6.1 Abbott
17.6.1.1 Company overview
17.6.1.2 Alere, Inc.
17.6.1.3 Financial performance
17.6.1.4 Product benchmarking
17.6.1.5 Strategic initiatives
17.6.2 Becton, Dickinson and Company
17.6.2.1 Company overview
17.6.2.2 Financial performance
17.6.2.3 Product benchmarking
17.6.2.4 Strategic initiatives
17.6.3 bioM?rieux SA
17.6.3.1 Company overview
17.6.3.2 Financial performance
17.6.3.3 Product benchmarking
17.6.3.4 Strategic initiatives
17.6.4 Bio-Rad Laboratories, Inc.
17.6.4.1 Company overview
17.6.4.2 Financial performance
17.6.4.3 Product benchmarking
17.6.4.4 Strategic initiatives
17.6.5 Agilent Technologies, Inc.
17.6.5.1 Company overview
17.6.5.2 Financial performance
17.6.5.3 Product benchmarking
17.6.5.4 Strategic initiatives
17.6.6 Danaher Corporation
17.6.6.1 Company overview
17.6.6.2 Cepheid
17.6.6.3 Beckman Coulter
17.6.6.4 Leica Biosystems
17.6.6.5 Financial performance
17.6.6.6 Product benchmarking
17.6.6.7 Strategic initiatives
17.6.6.8 Strategic initiatives of Cepheid
17.6.7 Hologic, Inc. (Gen Probe)
17.6.7.1 Company overview
17.6.7.2 Financial performance
17.6.7.3 Product benchmarking
17.6.7.4 Strategic initiatives
17.6.8 Illumina, Inc.
17.6.8.1 Company overview
17.6.8.2 Financial performance
17.6.8.3 Product benchmarking
17.6.8.4 Strategic initiatives
17.6.9 GRIFOLs S.A.
17.6.9.1 Company overview
17.6.9.2 Financial performance
17.6.9.3 Product benchmarking
17.6.9.4 Strategic initiatives
17.6.10 Qiagen
17.6.10.1 Company overview
17.6.10.2 Financial performance
17.6.10.3 Product benchmarking
17.6.10.4 Strategic initiatives
17.6.11 F. Hoffmann-La Roche Ltd
17.6.11.1 Company overview
17.6.11.2 Financial performance
17.6.11.3 Product benchmarking
17.6.11.4 Strategic initiatives
17.6.12 Siemens Healthineers
17.6.12.1 Company overview
17.6.12.2 Financial performance
17.6.12.3 Product benchmarking
17.6.12.4 Strategic initiatives
17.6.13 Sysmex Corporation
17.6.13.1 Company overview
17.6.13.2 Financial performance
17.6.13.3 Product benchmarking
17.6.13.4 Strategic initiatives
LIST OF TABLES
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Infectious Disease Molecular Diagnostics Market, By Region, 2017 - 2028 (USD Million)
TABLE 5 Global Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 6 Global Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 7 Global Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 8 Global Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 9 Global Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 10 Global Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 11 Global Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 12 Global Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 13 Global Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 14 Global Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 15 Global Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 16 Global Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 17 North America Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 18 North America Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 19 North America Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 20 North America Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 21 North America Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 22 North America Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 23 North America Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 24 North America Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 25 North America Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 26 North America Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 27 North America Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 28 North America Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 29 North America Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 30 U.S. Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 31 U.S. Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 32 U.S. Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 33 U.S. Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 34 U.S. Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 35 U.S. Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 36 U.S. Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 37 U.S. Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 38 U.S. Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 39 U.S. Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 40 U.S. Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 41 U.S. Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 42 Canada Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 43 Canada Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 44 Canada Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 45 Canada Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 46 Canada Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 47 Canada Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 48 Canada Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 49 Canada Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 50 Canada Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 51 Canada Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 52 Canada Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 53 Canada Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 54 Europe Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 55 Europe Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 56 Europe Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 57 Europe Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 58 Europe Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 59 Europe Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 60 Europe Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 61 Europe Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 62 Europe Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 63 Europe Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 64 Europe Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 65 Europe Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 66 Europe Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 67 U.K. Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 68 U.K. Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 69 U.K. Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 70 U.K. Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 71 U.K. Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 72 U.K. Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 73 U.K. Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 74 U.K. Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 75 U.K. Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 76 U.K. Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 77 U.K. Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 78 U.K. Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 79 Germany Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 80 Germany America Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 81 Germany America Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 82 Germany America Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 83 Germany Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 84 Germany Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 85 Germany Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 86 Germany Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 87 Germany Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 88 Germany Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 89 Germany Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 90 Germany Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 91 France Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 92 France Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 93 France Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 94 France Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 95 France Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 96 France Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 97 France Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 98 France Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 99 France Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 100 France Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 101 France Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 102 France Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 103 Spain Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 104 Spain Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 105 Spain Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 106 Spain Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 107 Spain Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 108 Spain Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 109 Spain Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 110 Spain Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 111 Spain Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 112 Spain Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 113 Spain Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 114 Spain Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 115 Italy Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 116 Italy Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 117 Italy Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 118 Italy Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 119 Italy Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 120 Italy Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 121 Italy Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 122 Italy Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 123 Italy Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 124 Italy Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 125 Italy Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 126 Italy Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 127 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 128 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 129 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 130 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 131 Asia Pacific Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 132 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 133 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 134 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 135 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 136 Asia Pacific Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 137 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 138 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 139 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 140 China Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 141 China Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 142 China Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 143 China Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 144 China Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 145 China Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 146 China Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 147 China Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 148 China Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 149 China Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 150 China Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 151 China Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 152 Japan Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 153 Japan Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 154 Japan Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 155 Japan Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 156 Japan Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 157 Japan Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 158 Japan Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 159 Japan Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 160 Japan Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 161 Japan Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 162 Japan Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 163 Japan Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 164 India Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 165 India Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 166 India Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 167 India Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 168 India Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 169 India Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 170 India Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 171 India Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 172 India Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 173 India Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 174 India Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 175 India Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 176 South Korea Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 177 South Korea Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 178 South Korea Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 179 South Korea Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 180 South Korea Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 181 South Korea Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 182 South Korea Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 183 South Korea Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 184 South Korea Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 185 South Korea Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 186 South Korea Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 187 South Korea Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 188 Australia Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 189 Australia Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 190 Australia Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 191 Australia Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 192 Australia Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 193 Australia Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 194 Australia Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 195 Australia Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 196 Australia Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 197 Australia Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 198 Australia Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 199 Australia Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 200 Latin America Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Infectious Disease Molecular Diagnostics Market, By Region, 2017 - 2028 (USD Million)
TABLE 5 Global Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 6 Global Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 7 Global Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 8 Global Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 9 Global Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 10 Global Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 11 Global Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 12 Global Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 13 Global Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 14 Global Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 15 Global Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 16 Global Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 17 North America Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 18 North America Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 19 North America Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 20 North America Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 21 North America Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 22 North America Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 23 North America Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 24 North America Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 25 North America Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 26 North America Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 27 North America Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 28 North America Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 29 North America Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 30 U.S. Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 31 U.S. Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 32 U.S. Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 33 U.S. Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 34 U.S. Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 35 U.S. Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 36 U.S. Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 37 U.S. Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 38 U.S. Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 39 U.S. Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 40 U.S. Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 41 U.S. Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 42 Canada Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 43 Canada Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 44 Canada Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 45 Canada Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 46 Canada Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 47 Canada Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 48 Canada Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 49 Canada Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 50 Canada Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 51 Canada Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 52 Canada Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 53 Canada Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 54 Europe Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 55 Europe Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 56 Europe Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 57 Europe Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 58 Europe Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 59 Europe Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 60 Europe Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 61 Europe Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 62 Europe Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 63 Europe Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 64 Europe Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 65 Europe Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 66 Europe Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 67 U.K. Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 68 U.K. Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 69 U.K. Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 70 U.K. Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 71 U.K. Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 72 U.K. Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 73 U.K. Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 74 U.K. Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 75 U.K. Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 76 U.K. Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 77 U.K. Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 78 U.K. Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 79 Germany Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 80 Germany America Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 81 Germany America Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 82 Germany America Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 83 Germany Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 84 Germany Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 85 Germany Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 86 Germany Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 87 Germany Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 88 Germany Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 89 Germany Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 90 Germany Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 91 France Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 92 France Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 93 France Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 94 France Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 95 France Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 96 France Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 97 France Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 98 France Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 99 France Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 100 France Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 101 France Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 102 France Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 103 Spain Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 104 Spain Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 105 Spain Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 106 Spain Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 107 Spain Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 108 Spain Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 109 Spain Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 110 Spain Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 111 Spain Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 112 Spain Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 113 Spain Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 114 Spain Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 115 Italy Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 116 Italy Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 117 Italy Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 118 Italy Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 119 Italy Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 120 Italy Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 121 Italy Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 122 Italy Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 123 Italy Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 124 Italy Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 125 Italy Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 126 Italy Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 127 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 128 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 129 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 130 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 131 Asia Pacific Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 132 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 133 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 134 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 135 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 136 Asia Pacific Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 137 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 138 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 139 Asia Pacific Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 140 China Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 141 China Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 142 China Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 143 China Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 144 China Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 145 China Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 146 China Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 147 China Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 148 China Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 149 China Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 150 China Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 151 China Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 152 Japan Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 153 Japan Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 154 Japan Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 155 Japan Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 156 Japan Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 157 Japan Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 158 Japan Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 159 Japan Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 160 Japan Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 161 Japan Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 162 Japan Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 163 Japan Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 164 India Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 165 India Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 166 India Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 167 India Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 168 India Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 169 India Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 170 India Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 171 India Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 172 India Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 173 India Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 174 India Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 175 India Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 176 South Korea Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 177 South Korea Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 178 South Korea Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 179 South Korea Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 180 South Korea Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 181 South Korea Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 182 South Korea Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 183 South Korea Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 184 South Korea Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 185 South Korea Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 186 South Korea Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 187 South Korea Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 188 Australia Infectious Disease Molecular Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 189 Australia Infectious Disease Molecular Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 190 Australia Infectious Disease Molecular Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 191 Australia Infectious Disease Molecular Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 192 Australia Infectious Disease Molecular Diagnostics Market, By Respiratory Diseases, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 193 Australia Infectious Disease Molecular Diagnostics Market, By Tuberculosis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 194 Australia Infectious Disease Molecular Diagnostics Market, By Meningitis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 195 Australia Infectious Disease Molecular Diagnostics Market, By Gastrointestinal Tract Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 196 Australia Infectious Disease Molecular Diagnostics Market, By HPV, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 197 Australia Infectious Disease Molecular Diagnostics Market, By Sexually Transmitted Infections, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 198 Australia Infectious Disease Molecular Diagnostics Market, By Sepsis, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 199 Australia Infectious Disease Molecular Diagnostics Market, By Drug Resistance Disease, 2017 - 2028 (Revenue, USD Million, 2017 - 2028) (Number of Tests Performed from 2020 - 2028 in Million)
TABLE 200 Latin America Infectious Disease Molecular Diagnostics Market, By Country, 2017 - 2028 (USD Million)
LIST OF FIGURES
Fig. 1 Infectious disease molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Infectious Disease Molecular Diagnostics Market Outlook (2020)
Fig. 9 User perspective analysis
Fig. 1 Infectious disease molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Infectious Disease Molecular Diagnostics Market Outlook (2020)
Fig. 9 User perspective analysis
